Questions 48 - 50 Diabetes. 48. NIDDM response The figure below shows the ‘normal’ response of blood glucose (solid line) and insulin (dashed line) concentrations.

Slides:

Advertisements

Similar presentations

AB 11 22 33 44 55 66 77 88 99 10  20  19  18  17  16  15  14  13  12  11  21  22  23  24  25  26  27  28.

Advertisements

Diabetes mellitus Dr. Essam H. Jiffri.

The Review Digestive and Endocrine Systems Final Format: 15 Multiple Choice 1 Identification 2 Short Answer 1 Essay.

Diabetes Mellitus (“sweet urine”) : Metabolic disorder characterized by high blood sugar (glucose) levels resulting from defects in insulin secretion or.

Blood Glucose Test Dept.of Biochemistry. Determination of glucose concentration is important in the diagnosis and treatment of disorders of carbohydrate.

Diabetes Mellitus and Osteoporosis

Chelsea McCarty, Professor Salt Lake Community College Fall 2010.

Diabetes Mellitus. What´s Diabetes? Diabetes is a group of metabolic alterations that lead to the increase of blood glucose concentration. Why there is.

Prevention of Type 2 Diabetes. Hyperglycemia in Type 2 Diabetes: Changing Treatment Paradigms.

DIABETES MELLITUS By Prarit Arora

Diabetes Past Present and Future Rich Hartmann 5/11/2010.

Glycogen storage disease

Glucose, quantitative determination

The control of blood sugar 1. Blood sugar levels are higher than normal after a meal is digested. 2.

Small Steps to Big Rewards Diabetes Prevention Program Slyter Nutrition Consulting Services

Keystone Review - Homeostasis 1.A – Shivering raises body temperature by generating heat in muscle tissue. 2.A – Excretion of a thick paste helps conserve.

Some diabetics inject insulin after a meal. Diabetics may carry a blood monitor to test the amount of glucose in the blood. Diabetics are recommended to.

Journal Club 亀田メディカルセンター糖尿病内分泌内科 Diabetes and Endocrine Department, Kameda Medical Center 松田昌文 Matsuda, Masafumi 2008 年１月 10 日 8:20-8:50 B 棟８階カンファレンス室.

Identify the risk factors, diagnosis and prevalence of diabetes in the United States. Describe the function of the pancreas, the intestines and liver.

Epidemiology of Diabetes in Hispanic Americans. Prevalence of Abnormal Glucose Tolerance in Three Ethnic Groups.

Normal Insulin Production Cells needs glucose Glucose is used by the mitochondria to make energy (ATP) After meals, glucose levels in the blood increase.

Math Graphing Linear Inequalities in Two Variables 1.

Diabetes. Warm Up Questions How many people do you know have diabetes? What is diabetes? Diabetes can be dangerous if it’s not treated. What happens if.

Date of download: 5/31/2016 From: Metabolic Risk Factors Worsen Continuously across the Spectrum of Nondiabetic Glucose Tolerance: The Framingham Offspring.

Date of download: 6/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of Health Maintenance Organization Coverage.

Whole blood was the sample of choice for analysis However, values for glucose in whole blood are less than in plasma since red blood cells contain only.

Risk of Progression to Type 2 Diabetes Based on Relationship Between Postload Plasma Glucose and Fasting Plasma Glucose Diabetes Division and the Clinical.

Diabetes Prevention.  29 million Americans have diabetes (9.3% of population)  2 million new cases each year  79 million Americans have pre diabetes.

DIABETES MELLITUS. Diabetes mellitus (DM) is a metabolic disorder resulting from a defect in insulin secretion, insulin action, or both. DM is associated.

Anesthes. 2008;108(3): doi: /ALN.0b013e Figure Legend:

BLOOD OR PLASMA GLUCOSE

GLUCOSE TOLERANCE TEST (GTT)

Diabetes Mellitus Nursing Management.

Glucose tolerance testing. A

Diabetes Mellitus Nursing Management.

Figure 2 Pathophysiology of hyperglycaemia in T2DM

המשותף לכל סוגי הסוכרת היפרגליקמיה כרונית.

Glycemic Control, Mealtime Glucose Excursions, and Diabetic Complications in Type 2 Diabetes Mellitus P.J. Palumbo, MD Mayo Clinic Proceedings Volume.

Sequential insulin strategies in type 2 diabetes.

Glucose Tolerance Test Physiology lab-3 February, 2018

Figure 3 Clinical algorithms in the management of NASH and diabetes mellitus Figure 3 | Clinical algorithms in the management of NASH and diabetes mellitus.

Selective versus Total Insulin Resistance: A Pathogenic Paradox

The Stunned β Cell: A Brief History

Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall.

Respondents’ perceptions on (A) the potential of IDegLira compared with basal-bolus therapy to improve patient motivation to reach their target blood glucose.

Patient Analysis Highlight the following information about your patient: What is the gender and age of your patient? What is the height and weight of your.

Mean daily glucose concentration and frequency of hypoglycemia in long-term care residents with type 2 diabetes. Mean daily glucose concentration and frequency.

Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease Francesco S. Facchini, Nancy.

Effects of laparoscopic ovarian drilling on serum vascular endothelial growth factor and on insulin responses to the oral glucose tolerance test in women.

Disorders Associated with Insulin and Glucagon

The insulin tolerance test at week 18.

TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin resistance. TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin.

Insulin secretion/insulin resistance (disposition) index (ΔINS/ΔGLU ÷ IR) in subjects with normal glucose tolerance (NGT), impaired glucose tolerance (IGT),

Left columns: Plasma glucose and serum insulin concentrations, circulating TF-PCA, and FVIIa activity before and during 24 h of selective hyperglycemia.

Patients with cystic fibrosis and normoglycemia exhibit diabetic glucose tolerance during pulmonary exacerbation Noa Nezer M. Sc, David Shoseyov, Eitan.

Glucose tolerance in WT and TRPM2-KO mice.

Transgenic restoration of long-chain n-3 PUFA protects against obesity-linked insulin resistance and glucose intolerance. Transgenic restoration of long-chain.

The underlying physiological basis of the HOMA model.

Effects of in vivo AICAR treatment on blood glucose and lactate concentrations. Effects of in vivo AICAR treatment on blood glucose and lactate concentrations.

The figure shows the mean±SD of glucose and insulin for the 2-hour OGTTs and MTTs for the 12 HP diet subjects and the 12 HC diets subjects. The figure.

Effect of 4 weeks of an intensive exercise program on vaspin serum concentrations in normal glucose tolerant (NGT) individuals and patients with IGT or.

Insulin resistance and hepatic steatosis in ASKO mice.

Effects of berberine on in vivo metabolism in two animal models of insulin resistance. Effects of berberine on in vivo metabolism in two animal models.

Oral glucose tolerance testing during hospitalization and at 4 months after infarction. Oral glucose tolerance testing during hospitalization and at 4 months.

WALT know diabetes. Type 1 diabetes Type 2 diabetes

Median (interquartile range) of sensor glucose (A) and insulin delivery (B) during closed-loop (solid red line and red shaded area) and control period.

Plasma glucose (A), serum insulin (B), serum C peptide (C) and plasma GLP-1 level (D) during the 2-hour OGTT among subjects with normal glucose tolerance.

Postoperative blood glucose levels and total insulin requirement.

Plasma concentration of metabolite M1 (left panel), glucose infusion rate (GIR) to maintain euglycemia (middle panel), and blood glucose concentration.

Glucose log of a 51-year-old patient with insulin-requiring type 2 diabetes and an A1C of 7.8% who takes 10 mg of glyburide at bedtime and 25 units of.

Presentation transcript:

Questions Diabetes

48. NIDDM response The figure below shows the ‘normal’ response of blood glucose (solid line) and insulin (dashed line) concentrations to a 50 g oral glucose load. Which response is characteristic of a TYPE II DIABETIC (Non-insulin dependent diabetes) AB D C E glucose tolerant high insulin glucose tolerant tiny insulin glucose intolerant, basal hyperinsulinemia, flat response glucose intolerant no insulin weird!!!

49. Insulin Resistance The figure below shows the ‘normal’ response of blood glucose (solid line) and insulin (dashed line) concentrations to a 50 g oral glucose load. Which response is characteristic of someone who is glucose tolerant but insulin resistant? AB D C E glucose tolerant high insulin glucose tolerant tiny insulin glucose intolerant, basal hyperinsulinemia, flat response glucose intolerant no insulin weird!!!

50. IDDM The figure below shows the ‘normal’ response of blood glucose (solid line) and insulin (dashed line) concentrations to a 50 g oral glucose load. Which response is characteristic of a TYPE I DIABETIC (Insulin dependent diabetes) AB D C E glucose tolerant high insulin glucose tolerant tiny insulin glucose intolerant, basal hyperinsulinemia, flat response glucose intolerant no insulin weird!!!